Unlock instant, AI-driven research and patent intelligence for your innovation.

Monoclonal antibody for resisting human NT-proBNP polypeptide

A monoclonal antibody, nt-probnp technology, applied in the direction of anti-animal/human immunoglobulin, anti-hormonal immunoglobulin, etc., can solve problems such as poor repeatability, poor clinical relevance of characterization, and complicated sample pretreatment methods, and achieve Simple preparation process, high antibody affinity, good protein surface activity and antigenic effect

Inactive Publication Date: 2019-06-28
蕲泰和瑞生物科技(武汉)有限公司
View PDF6 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In addition, there are other assays for different amino acid segments, but these methods suffer from poor reproducibility, complicated sample pretreatment methods, poor characterization and / or clinical relevance, etc.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Monoclonal antibody for resisting human NT-proBNP polypeptide

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0023] 1). Select NT-proBNP epitope polypeptide fragments aa1 and aa2:

[0024] DNAstar (Genetool) software was used to analyze the protein structure and antigenic epitope of the full-length amino acid sequence of human NT-proBNP in the early stage. According to the optimal conditions, two polypeptide fragments aa1 and aa2 were selected. The aa1 is SEQ ID NO.1. The sequence shown, the aa2 is the sequence shown in SEQ ID NO.2. The sequence SEQ ID NO.1 and the sequence SEQ ID NO.2 are as follows:

[0025] Sequence SEQ ID NO.1: ETSGLQEQRNHL

[0026] Sequence SEQ ID NO.2: IRGHRKMVLYTLRAPR

[0027] 2). Preparation of NT-proBNP epitope polypeptide fragments aa1 and aa2:

[0028] Weigh 100 mg of HMP resin and place it in the reaction chamber of an automatic peptide synthesizer, and the synthesizer automatically couples specific amino acids in different sequences, and the coupling rate is greater than 99%. The reaction steps are as follows:

[0029] ①Amino acid activation (HOBt / D...

Embodiment 2

[0058] 1). Select NT-proBNP epitope polypeptide fragments aa1 and aa2, the method is the same as in Example 1;

[0059] 2). Preparation of NT-proBNP epitope polypeptide fragments aa1 and aa2:

[0060] Weigh 100 mg of HMP resin and place it in the reaction chamber of an automatic peptide synthesizer, and the synthesizer automatically couples specific amino acids in different sequences, and the coupling rate is greater than 99%. The reaction steps are as follows:

[0061] ①Amino acid activation (HOBt / DCC method): take 0.15mol Fmoc-Ile and 0.15mol HOBt, dissolve with appropriate amount of DMF; take another 0.15molDCC, add slowly under stirring, stir and react at room temperature for 50 minutes, and obtain The activated amino acid solution is set aside;

[0062] ② Linking amino acids to the resin: under the action of a coupling reagent, the activated amino acid solution and the resin carrier (Wang resin) are subjected to an esterification reaction, and the reaction time is 250 m...

Embodiment 3

[0087] 1). Select NT-proBNP epitope polypeptide fragments aa1 and aa2, the method is the same as in Example 1;

[0088] 2). Prepare NT-proBNP epitope polypeptide fragments aa1 and aa2;

[0089] Weigh 100 mg of HMP resin and place it in the reaction chamber of an automatic peptide synthesizer, and the synthesizer automatically couples specific amino acids in different sequences, and the coupling rate is greater than 99%. The reaction steps are as follows:

[0090] ①Activation of amino acid (HOBt / DCC method): take 0.15mol Fmoc-Gln and 0.15mol HOBt, dissolve with appropriate amount of DMF; take another 0.15molDCC, add slowly under stirring, stir and react at room temperature for 40 minutes, and obtain after filtration The activated amino acid solution is set aside;

[0091] ② Linking amino acids to the resin: under the action of a coupling reagent, the activated amino acid solution and the resin carrier (Wang resin) are subjected to an esterification reaction, and the reaction ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a monoclonal antibody for resisting human NT-proBNP polypeptide. A method comprises the steps that NT-proBNP antigenic determinant polypeptide fragments aa1 and aa2 are selected and prepared, and coupling protein aa1-KLH-aa2 is formed and used as the monoclonal antibody for preparing anti-human NT-proBNP polypeptide for an antigen immune animal. The coupling protein prepared in the production process has good protein surface activity and antigenicity, the monoclonal antibody with good specificity is conveniently screened out, through the coupling protein, the number ofantigenic determinants can be increased, the production kind of the monoclonal antibody is increased, and the pairing possibility of the monoclonal antibody in the later period is improved. The preparation process is simple, the antibody affinity is high, and the monoclonal antibody has wide market prospects.

Description

technical field [0001] The invention relates to the technical field of antibody engineering, in particular to a monoclonal antibody against human NT-proBNP polypeptide. Background technique [0002] With the improvement of living conditions and medical conditions, the phenomenon of social aging is becoming more and more obvious, and the number of heart failure patients is increasing year by year. Heart failure is a clinical syndrome of signs and symptoms due to cardiac dysfunction. Although some drugs can slow the progression of the disease, heart failure is incurable without a heart transplant. Early diagnosis of heart failure is the most critical issue facing healthcare today, and the sooner treatment can be started, the better for the patient. However, heart failure (especially in its early stages) is difficult to diagnose. The typical symptoms of heart failure, such as fatigue, shortness of breath, ankle swelling, etc., are not specific, and some patients with mild il...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07K16/26
Inventor 闫金勇詹雷雷骆锟
Owner 蕲泰和瑞生物科技(武汉)有限公司